Our Mission
is to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC protein degradation platform.

Smiling male Arvinas staffer conducting experiment
Doctor and Patient Talking
We create proteolysis targeting chimeras (PROTAC) degraders

We are Arvinas, a clinical-stage biotechnology company leading the way in the development of targeted protein degradation therapeutics.

We are singularly focused on developing an entirely new class of medicines that aims to be transformative for patients and their health care providers, turning targeted protein degradation into one of the promising areas of medical research and challenging the perceived limits of drug discovery.

We create proteolysis targeting chimeras (PROTAC) degraders
Smiling Arvinas scientific staff member talking with colleague
Arvinas scientific staff
Scientist with desktop

If you’re inspired, please take a look at the current list of opportunities to join our team.

Our Hope is to Revolutionize Drug Discovery

Our team is driving some of the significant breakthroughs in the industry and enabling an expansive pipeline of targets in oncology and neuroscience.

Together, we are bringing novel investigational research to patients who need it most. With multiple products in development, we are exploring how PROTAC protein degraders bridge our preclinical platform into the clinic.

Learn more about our therapeutic programs.

Smiling Arvinas scientific staff member talking with colleague
Arvinas scientific staff preparing materials for testing
Smiling Arvinas scientific staff member talking with colleagues

We’re excited about the work we’re doing inside and outside of Arvinas, and think you will be, too.